Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.
2.

Rapidly growing mycobacteria infections among "cosmetic tourists" returning to the Netherlands.

Ovadja ZN, Sluijmer H, Moerman E, van Ogtrop M, Lapid O.

J Plast Reconstr Aesthet Surg. 2018 Feb;71(2):265-267. doi: 10.1016/j.bjps.2017.10.023. Epub 2017 Nov 2. No abstract available.

PMID:
29175134
3.

An unusual peripheral blood smear.

de Hoog SH, Blok WL, van Ogtrop ML, van den Berk GE.

Neth J Med. 2014 Jul;72(6):332, 336. No abstract available.

4.

Verified clinical failure with cefotaxime 1g for treatment of gonorrhoea in the Netherlands: a case report.

van Dam AP, van Ogtrop ML, Golparian D, Mehrtens J, de Vries HJ, Unemo M.

Sex Transm Infect. 2014 Nov;90(7):513-4. doi: 10.1136/sextrans-2014-051552. Epub 2014 Aug 11.

PMID:
25114322
5.

Presence of tobramycin in blood and urine during selective decontamination of the digestive tract in critically ill patients, a prospective cohort study.

Oudemans-van Straaten HM, Endeman H, Bosman RJ, Attema-de Jonge ME, van Ogtrop ML, Zandstra DF, Franssen EJ.

Crit Care. 2011;15(5):R240. doi: 10.1186/cc10489. Epub 2011 Oct 17.

6.

[Prevention of nosocomial infections after cardiac surgery by decontamination of the nasopharynx and oropharynx with chlorhexidine; a prospective, randomised study].

Segers P, Speekenbrink RG, Ubbink DT, van Ogtrop ML, de Mol BA.

Ned Tijdschr Geneeskd. 2008 Mar 29;152(13):760-7. Dutch.

PMID:
18461895
7.
8.

CS-834 (Sankyo).

van Ogtrop ML.

IDrugs. 1999 Mar;2(3):254-8.

PMID:
16160937
9.

In vivo pharmacodynamics of a new oxazolidinone (linezolid).

Andes D, van Ogtrop ML, Peng J, Craig WA.

Antimicrob Agents Chemother. 2002 Nov;46(11):3484-9.

10.

The diagnostic value of streptococcal serology in early arthritis: a prospective cohort study.

Visser H, Speyer I, Ozcan B, Breedveld FC, van Ogtrop ML, Hazes JM.

Rheumatology (Oxford). 2000 Dec;39(12):1351-6.

PMID:
11136878
11.

In vivo pharmacodynamic activities of two glycylcyclines (GAR-936 and WAY 152,288) against various gram-positive and gram-negative bacteria.

van Ogtrop ML, Andes D, Stamstad TJ, Conklin B, Weiss WJ, Craig WA, Vesga O.

Antimicrob Agents Chemother. 2000 Apr;44(4):943-9.

12.
13.

Occurrence of extended-spectrum betalactamases (ESBL) in Dutch hospitals.

Stobberingh EE, Arends J, Hoogkamp-Korstanje JA, Goessens WH, Visser MR, Buiting AG, Debets-Ossenkopp YJ, van Ketel RJ, van Ogtrop ML, Sabbe LJ, Voorn GP, Winter HL, van Zeijl JH.

Infection. 1999 Nov-Dec;27(6):348-54.

PMID:
10624595
14.

Use of pharmacodynamic indices to predict efficacy of combination therapy in vivo.

Mouton JW, van Ogtrop ML, Andes D, Craig WA.

Antimicrob Agents Chemother. 1999 Oct;43(10):2473-8.

17.

Serratia marcescens infections in neonatal departments: description of an outbreak and review of the literature.

van Ogtrop ML, van Zoeren-Grobben D, Verbakel-Salomons EM, van Boven CP.

J Hosp Infect. 1997 Jun;36(2):95-103. Review.

PMID:
9211156
18.

Insufficient evidence of synergistic effect of levofloxacin and rifampin against Legionella pneumophila.

van Ogtrop ML.

Antimicrob Agents Chemother. 1996 Feb;40(2):524-5. No abstract available.

19.

Effect of broth enrichment cultures on ability to detect carriage of Staphylococcus aureus.

van Ogtrop ML.

Antimicrob Agents Chemother. 1995 Sep;39(9):2169. No abstract available.

20.

Septicaemia, meningitis and spondylodiscitis caused by Streptococcus suis type 2.

Arend SM, van Buchem MA, van Ogtrop ML, Thompson J.

Infection. 1995 Mar-Apr;23(2):128. No abstract available.

PMID:
7622264
21.

Fatal fungal peritonitis by Trichoderma longibrachiatum complicating peritoneal dialysis.

Tanis BC, van der Pijl H, van Ogtrop ML, Kibbelaar RE, Chang PC.

Nephrol Dial Transplant. 1995;10(1):114-6. No abstract available.

PMID:
7724005
22.

Comparison of the antibacterial effects of cefepime and ceftazidime against Escherichia coli in vitro and in vivo.

Mattie H, Sekh BA, van Ogtrop ML, van Strijen E.

Antimicrob Agents Chemother. 1992 Nov;36(11):2439-43.

23.
24.

Modulation of the intestinal flora of mice by treatment with aztreonam and tigemonam.

van Ogtrop ML, Guiot HF, Mattie H, van Strijen E, Sekh BR, van Furth R.

Antimicrob Agents Chemother. 1991 May;35(5):983-5.

25.

Modulation of the intestinal flora of mice by parenteral treatment with broad-spectrum cephalosporins.

van Ogtrop ML, Guiot HF, Mattie H, van Furth R.

Antimicrob Agents Chemother. 1991 May;35(5):976-82.

26.

Comparison of the effects of aztreonam and tigemonam against Escherichia coli and Klebsiella pneumoniae in vitro and in vivo.

van Ogtrop ML, Mattie H, Guiot HF, van Strijen E, Sekh BR, van Furth R.

Antimicrob Agents Chemother. 1991 Mar;35(3):417-22.

27.

Comparative study of the effects of four cephalosporins against Escherichia coli in vitro and in vivo.

van Ogtrop ML, Mattie H, Guiot HF, van Strijen E, Hazekamp-van Dokkum AM, van Furth R.

Antimicrob Agents Chemother. 1990 Oct;34(10):1932-7.

28.
29.

Decontaminating efficacy of ciprofloxacin in an animal model.

van Ogtrop ML, Mattie H, Guiot HF, van Furth R.

Eur J Clin Microbiol Infect Dis. 1989 Oct;8(10):901-3.

PMID:
2512138

Supplemental Content

Loading ...
Support Center